According to CoinMeta, AstraZeneca announced a collaboration with Insitro to invest $1.86 billion in the research and development of drugs for fatty liver and myocardial diseases. Analysts say that AI pharmaceuticals will significantly improve the efficiency and quality of drug development. In addition, the construction of six networks is underway, with computing power and the power grid working together to advance the Shaoguan data center cluster's integrated power project for generation, transmission, load, storage, and power consumption. The stock price of iambic therapeutics rose by 18.19%; this company, which invests in AI pharmaceutical enterprises for NVIDIA, went public on the NASDAQ exchange on Thursday.